Insulin aspart, recombinant Subcutaneous and Tracleer (Bosentan Tablets)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tracleer (Bosentan Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bosentan
Brand name: Tracleer
Synonyms: Tracleer
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tradjenta
- Insulin aspart, recombinant Subcutaneous-Tramacet
- Insulin aspart, recombinant Subcutaneous-Tramadol
- Insulin aspart, recombinant Subcutaneous-Tramadol and acetaminophen
- Insulin aspart, recombinant Subcutaneous-Tramadol Capsules
- Insulin aspart, recombinant Subcutaneous-Tramadol ER
- Tracleer (Bosentan Tablets)-Insulin degludec
- Tracleer (Bosentan Tablets)-Insulin Degludec (U-100) Prefilled Pens
- Tracleer (Bosentan Tablets)-Insulin Degludec (U-100) Vials
- Tracleer (Bosentan Tablets)-Insulin Degludec (U-200) Prefilled Pens
- Tracleer (Bosentan Tablets)-Insulin degludec and liraglutide
- Tracleer (Bosentan Tablets)-Insulin degludec and liraglutide Subcutaneous